Did CareDx throw itself under the bus in terminating LabCorp lupus test deal?

CareDx, LabCorp Terminate Lupus Test Deal | GenomeWeb

As part of the agreement to terminate the collaboration, CareDx is transferring and assigning to LabCorp 300 “SAGE 1” clinical samples, as well as other clinical data and documentation that CareDx gathered from patients during the discovery phase of the collaboration.

CareDx also is granting LabCorp a perpetual, non-exclusive, worldwide, royalty-free license to use any IP and data resulting from the collaboration for any purpose. In return, LabCorp will pay CareDx $500,000. No other royalties, milestone fees, or other fees will be payable by LabCorp.

via CareDx, LabCorp Terminate Lupus Test Deal | GenomeWeb.


All those law firms that are looking into LabCorp’s acquisition of Covance should consider how well the shareholders of CareDx made out in the making and breaking of this “deal.”

About Susan Chandler

Now-disabled interior/exterior designer dragged into battling conviction corruption from its periphery in a third personal battle with civil public corruption.
This entry was posted in Uncategorized and tagged , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.